PATENT CLAIM ANALYSIS

Application Number: 15959195
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-08
Patent Classification: ["424", "094200"]

Abstract:
Provided herein are compositions containing a lysosomal storage disorder replacement enzyme (LSDRE) and a dispersing agent for subcutaneous injection for treatment of lysosomal storage diseases. Kits and methods of treatment are also provided.

Claim (Index 4):
The composition of  claim 1 , wherein the stable formulation is aqueous and is stable for at least 3 months when stored at 2-8\u00b0 C.

Metadata:
- Claim Count in Document: 1.0
- Percentile: 91.0
- Lexical Diversity: 1.32143
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15093613', '14774257', '15116122', '12175610', '13168963']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.6928625361238758
- 35 USC 102 Novelty (BERT): 0.611948691141866
- Combined Prediction Score: 0.6847711516256748
- Mean Citation Score: 263.337696
- Max Citation Score: 523.9092
- Similarity Product: 522.209991072321

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test